Navigation Links
22 of America's Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences
Date:6/13/2011

PHILADELPHIA, June 14, 2011 /PRNewswire-USNewswire/ -- Twenty-two of America's most promising scientists have been named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts.  The 2011 Pew Scholars will join a select community that includes MacArthur Fellows, recipients of the Albert Lasker Medical Research Award and three Nobel Prize winners.  Research by the new class of Scholars is related to many human diseases ranging from Alzheimer's to diabetes to ocular degeneration. The program encourages early-career scientists to advance research that leads to important medical breakthroughs and treatments.

"Pew is pleased to provide this country's most ambitious and dedicated scientists with timely funding that enables them to explore novel areas of investigation early in their careers, at what may be the most inventive and creative period in their research," said Rebecca W. Rimel, president and CEO of The Pew Charitable Trusts.

CLICK HERE TO SEE A VIDEO SHOWCASING THE WORK OF THE BIOMEDICAL SCHOLARS

To date, the program has invested more than $125 million to fund over 500 scholars. It is a rigorously competitive program where recipients receive $240,000 over four years to pursue their research without restriction. Applicants who work in all areas of physical and life sciences related to biomedical study must be nominated by an invited institution and demonstrate both excellence and innovation in their research. This year, 175 institutions were requested to nominate a candidate and 136 eligible nominations were received.

"Early recognition of young scientists with ideas that challenge their fields is essential for the vitality of the biomedical sciences," said Craig C. Mello, Ph.D., a 1995 Pew Scholar, a 2006 Nobel Laureate in Physiology or Medicine and the chair of the national advisory committee for the program. "From my own experience as a Pew Scholar and member of the advisory board, this program gives young scientists the confidence to pursue risky projects, and to push the boundaries of their fields, planting the seeds for major scientific advancements.  I welcome these promising scientists into the Pew Biomedical Scholars family and look forward to watching as their research unfolds in the years ahead."

The new 2011 Pew Scholars are:


  • Christine M. Dunham, Ph.D.

  • Emory University School of Medicine Structural Biology and Pathogenesis


  • Thomas G. Fazzio, Ph.D.

  • University of Massachusetts Medical SchoolStem Cell Biology


  • Max L. Fletcher, Ph.D.

  • University of Tennessee Health Science CenterNeuroscience


  • Hunter B. Fraser, Ph.D.

  • Stanford UniversityGene Regulation


  • Melissa K. Gardner, Ph.D.

  • University of MinnesotaCell Biology and Biophysics


  • Mary Gehring, Ph.D.

  • Whitehead Institute for Biomedical ResearchGene Regulation and Epigenetics


  • Jeff Gore, Ph.D.

  • Massachusetts Institute of TechnologyBiophysics and Systems Biology


  • Takaki Komiyama, Ph.D.

  • University of California, San DiegoNeuroscience


  • Mei Kong, Ph.D.

  • Beckman Institute, City of Hope Cancer Cell Biology


  • Michael S. Kuhns, Ph.D.

  • University of ArizonaImmunology


  • Erica Larschan, Ph.D.

  • Brown UniversityEpigenetics


  • Eros Lazzerini Denchi, Ph.D.

  • Scripps Research InstituteAging and Stem Cell Biology


  • Ann C. Morris, Ph.D.

  • University of KentuckyDevelopmental Neurobiology and Genetics


  • James B. Moseley, Ph.D.

  • Dartmouth Medical SchoolCell Biology


  • Suzanne M. Nobel, M.D., Ph.D.

  • University of California, San FranciscoFungal Pathogenesis


  • Brad J. Nolen, Ph.D.

  • University of OregonStructural Biology


  • Chad G. Pearson, Ph.D.

  • University of Colorado, DenverCell Biology


  • Sharad Ramanathan, Ph.D.

  • Harvard University Neuroscience and Systems Biology


  • Anthony R. Richardson, Ph.D.

  • University of North Carolina at Chapel HillMicrobiology and Immunology


  • Niels Ringstad, Ph.D.

  • New York University School of MedicineNeuroscience


  • Georgios Skiniotis, Ph.D.

  • University of MichiganStructural Biology and Membrane Biology


  • Liang Zhou, M.D., Ph.D.

  • Northwestern UniversityImmunology and Gene RegulationFor full biographies and information regarding the scholars' research, please visit www.pewscholars.org.

    The Pew Charitable Trusts (www.pewtrusts.org) is driven by the power of knowledge to solve today's most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public and stimulate civic life. We partner with a diverse range of donors, public and private organizations and concerned citizens who share our commitment to fact-based solutions and goal-driven investments to improve society.


    '/>"/>
    SOURCE The Pew Charitable Trusts
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Terumo Americas Holding, Inc., Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
    2. iLife Americas, LLC Enters U.S. Wellness and Therapeutic Markets
    3. Americas on the Waterway Supports US Oncology Foundation
    4. Cochlear Americas Provides Support for Cochlear Implant Recipients to Pursue Higher Education
    5. Abbott to Present at UBS Best of Americas Investment Conference
    6. Jennerex and Partners Present Positive JX-594 Randomized Phase 2 Clinical Data Showing Promising Survival Benefit in Patients with Advanced Liver Cancer
    7. Ontario Institute for Cancer Research Announces Spin Off Companies Developing Promising Anticancer Technologies
    8. Reportlinker Adds Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients
    9. Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B
    10. New findings promising for transformation optics, cloaking
    11. New hydrolysis model promising tool in cellulosic biofuel studies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
    (Date:6/24/2016)... ... 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona combed ... pleural mesothelioma. Their findings are the subject of a new article on the Surviving ... signposts in the blood, lung fluid or tissue of mesothelioma patients that can help ...
    (Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of the ... brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing ... to its list of well-respected retailers. This list includes such fine stores as ...
    (Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
    Breaking Biology Technology:
    (Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
    (Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
    (Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
    Breaking Biology News(10 mins):